8 Change in AKR1B10, TREM2 and CFHR4 protein levels in participants with MASH treated with semaglutide compared with protein levels in healthy volunteers in an independent real-world observational cohort
Wegovy tablets are prescribed for adults with a BMI of 30 or above, or a BMI of 27 or above with a weight-related health condition such as high blood pressure, high cholesterol, or type 2 diabetes
Read more Treatment information Product Name: Wegovy Manufacturer: Novo Nordisk Active Ingredient(s): Semaglutide Administration: Subcutaneous injection Presentation: Injectable solution Available Strength: 0.25, 0.5, 1.0, 1.7, 2.4, 7.2 mg Exemption: Prescription Only Dosage: Once a week Description: Wegovy is a weekly injection that aids weight loss Drug Class: GLP-1 analogue Alcohol Consumption: Avoid or limit alcohol consumption When Pregnant: Do not take Wegovy if you are pregnant Price: 109.99 GBP Image: Click here to view the Wegovy - Patient Information Leaflet Authored By Leanne is a science and health content writer focusing on human health and biology while utilising her solid academic background
If you have type 2 diabetes and use a sulfonylurea (e.g., glipizide, glimepiride, glyburide) or insulin, then consult your primary healthcare provider and/or endocrinologist to ensure the treatment is safe for you with careful monitoring
Your cart is empty Start Shopping
